The impact of structural optical coherence tomography changes on visual function in retinal vein occlusion
Purpose We aimed to determine the correlation between optical coherence tomography (OCT)‐ and demographic features and baseline best corrected visual acuity (BCVA) in treatment‐naïve patients with retinal vein occlusion (RVO). Methods This was a cross‐sectional posthoc analysis of OCT images that in...
Saved in:
| Published in | Acta ophthalmologica (Oxford, England) Vol. 99; no. 4; pp. 418 - 426 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Malden
Wiley Subscription Services, Inc
01.06.2021
John Wiley and Sons Inc |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Purpose
We aimed to determine the correlation between optical coherence tomography (OCT)‐ and demographic features and baseline best corrected visual acuity (BCVA) in treatment‐naïve patients with retinal vein occlusion (RVO).
Methods
This was a cross‐sectional posthoc analysis of OCT images that included RVO patients from two prospective, open‐label, multicentre studies. The morphological grading was done manually, in the standardized setting of a reading centre. Main outcome measure was the estimated difference in Early Treatment Diabetic Retinopathy Study letters associated with each individual biomarker.
Results
Included were 381/301 treatment‐naïve patients with BRVO/CRVO. For BRVO, statistically significant correlations with BCVA were seen for a 100 µm increase in central subfield thickness (CST; −3.1 letters), intraretinal cysts at centre point (CP; +4.1), subretinal fluid (SRF) at CP (+3.0) and hyperreflective foci (HRF) at the central B‐scan (−2.2). In CRVO, a 100 µm increase in CST was associated with a loss of −3.4 letters. In the total cohort, 100 µm increase in CST, SRF at CP and HRF at the central B‐scan correlated with a difference of −3.2,+3.2 and −2.0 letters. A 10‐year increase in age and female gender yielded a −2.0 and −2.5 letter decrease in the total cohort. Adjusted multiple R2 for the respective group was 18.3%/26.3%/23.5%.
Conclusions
Of all parameters studied, only CST and age were consistently associated with worse BCVA in treatment‐naïve RVO patients. Morphology on OCT explained only a modest part of functional loss in this patient cohort. |
|---|---|
| AbstractList | Purpose
We aimed to determine the correlation between optical coherence tomography (OCT)‐ and demographic features and baseline best corrected visual acuity (BCVA) in treatment‐naïve patients with retinal vein occlusion (RVO).
Methods
This was a cross‐sectional posthoc analysis of OCT images that included RVO patients from two prospective, open‐label, multicentre studies. The morphological grading was done manually, in the standardized setting of a reading centre. Main outcome measure was the estimated difference in Early Treatment Diabetic Retinopathy Study letters associated with each individual biomarker.
Results
Included were 381/301 treatment‐naïve patients with BRVO/CRVO. For BRVO, statistically significant correlations with BCVA were seen for a 100 µm increase in central subfield thickness (CST; −3.1 letters), intraretinal cysts at centre point (CP; +4.1), subretinal fluid (SRF) at CP (+3.0) and hyperreflective foci (HRF) at the central B‐scan (−2.2). In CRVO, a 100 µm increase in CST was associated with a loss of −3.4 letters. In the total cohort, 100 µm increase in CST, SRF at CP and HRF at the central B‐scan correlated with a difference of −3.2,+3.2 and −2.0 letters. A 10‐year increase in age and female gender yielded a −2.0 and −2.5 letter decrease in the total cohort. Adjusted multiple R2 for the respective group was 18.3%/26.3%/23.5%.
Conclusions
Of all parameters studied, only CST and age were consistently associated with worse BCVA in treatment‐naïve RVO patients. Morphology on OCT explained only a modest part of functional loss in this patient cohort. PURPOSEWe aimed to determine the correlation between optical coherence tomography (OCT)- and demographic features and baseline best corrected visual acuity (BCVA) in treatment-naïve patients with retinal vein occlusion (RVO). METHODSThis was a cross-sectional posthoc analysis of OCT images that included RVO patients from two prospective, open-label, multicentre studies. The morphological grading was done manually, in the standardized setting of a reading centre. Main outcome measure was the estimated difference in Early Treatment Diabetic Retinopathy Study letters associated with each individual biomarker. RESULTSIncluded were 381/301 treatment-naïve patients with BRVO/CRVO. For BRVO, statistically significant correlations with BCVA were seen for a 100 µm increase in central subfield thickness (CST; -3.1 letters), intraretinal cysts at centre point (CP; +4.1), subretinal fluid (SRF) at CP (+3.0) and hyperreflective foci (HRF) at the central B-scan (-2.2). In CRVO, a 100 µm increase in CST was associated with a loss of -3.4 letters. In the total cohort, 100 µm increase in CST, SRF at CP and HRF at the central B-scan correlated with a difference of -3.2,+3.2 and -2.0 letters. A 10-year increase in age and female gender yielded a -2.0 and -2.5 letter decrease in the total cohort. Adjusted multiple R2 for the respective group was 18.3%/26.3%/23.5%. CONCLUSIONSOf all parameters studied, only CST and age were consistently associated with worse BCVA in treatment-naïve RVO patients. Morphology on OCT explained only a modest part of functional loss in this patient cohort. PurposeWe aimed to determine the correlation between optical coherence tomography (OCT)‐ and demographic features and baseline best corrected visual acuity (BCVA) in treatment‐naïve patients with retinal vein occlusion (RVO).MethodsThis was a cross‐sectional posthoc analysis of OCT images that included RVO patients from two prospective, open‐label, multicentre studies. The morphological grading was done manually, in the standardized setting of a reading centre. Main outcome measure was the estimated difference in Early Treatment Diabetic Retinopathy Study letters associated with each individual biomarker.ResultsIncluded were 381/301 treatment‐naïve patients with BRVO/CRVO. For BRVO, statistically significant correlations with BCVA were seen for a 100 µm increase in central subfield thickness (CST; −3.1 letters), intraretinal cysts at centre point (CP; +4.1), subretinal fluid (SRF) at CP (+3.0) and hyperreflective foci (HRF) at the central B‐scan (−2.2). In CRVO, a 100 µm increase in CST was associated with a loss of −3.4 letters. In the total cohort, 100 µm increase in CST, SRF at CP and HRF at the central B‐scan correlated with a difference of −3.2,+3.2 and −2.0 letters. A 10‐year increase in age and female gender yielded a −2.0 and −2.5 letter decrease in the total cohort. Adjusted multiple R2 for the respective group was 18.3%/26.3%/23.5%.ConclusionsOf all parameters studied, only CST and age were consistently associated with worse BCVA in treatment‐naïve RVO patients. Morphology on OCT explained only a modest part of functional loss in this patient cohort. Abstract Purpose We aimed to determine the correlation between optical coherence tomography (OCT)‐ and demographic features and baseline best corrected visual acuity (BCVA) in treatment‐naïve patients with retinal vein occlusion (RVO). Methods This was a cross‐sectional posthoc analysis of OCT images that included RVO patients from two prospective, open‐label, multicentre studies. The morphological grading was done manually, in the standardized setting of a reading centre. Main outcome measure was the estimated difference in Early Treatment Diabetic Retinopathy Study letters associated with each individual biomarker. Results Included were 381/301 treatment‐naïve patients with BRVO/CRVO. For BRVO, statistically significant correlations with BCVA were seen for a 100 µm increase in central subfield thickness (CST; −3.1 letters), intraretinal cysts at centre point (CP; +4.1), subretinal fluid (SRF) at CP (+3.0) and hyperreflective foci (HRF) at the central B‐scan (−2.2). In CRVO, a 100 µm increase in CST was associated with a loss of −3.4 letters. In the total cohort, 100 µm increase in CST, SRF at CP and HRF at the central B‐scan correlated with a difference of −3.2,+3.2 and −2.0 letters. A 10‐year increase in age and female gender yielded a −2.0 and −2.5 letter decrease in the total cohort. Adjusted multiple R 2 for the respective group was 18.3%/26.3%/23.5%. Conclusions Of all parameters studied, only CST and age were consistently associated with worse BCVA in treatment‐naïve RVO patients. Morphology on OCT explained only a modest part of functional loss in this patient cohort. |
| Author | Michl, Martin Schmidt‐Erfurth, Ursula Sadeghipour, Amir Kaider, Alexandra Liu, Xuhui Gerendas, Bianca S. |
| AuthorAffiliation | 1 Department of Ophthalmology Vienna Reading Center and OPTIMA Study Group Medical University of Vienna Vienna Austria 3 Center for Medical Statistics Informatics and Intelligent Systems Medical University of Vienna Vienna Austria 2 Department of Ophthalmology The First Affiliated Hospital of Zhengzhou University Zhengzhou City China |
| AuthorAffiliation_xml | – name: 3 Center for Medical Statistics Informatics and Intelligent Systems Medical University of Vienna Vienna Austria – name: 1 Department of Ophthalmology Vienna Reading Center and OPTIMA Study Group Medical University of Vienna Vienna Austria – name: 2 Department of Ophthalmology The First Affiliated Hospital of Zhengzhou University Zhengzhou City China |
| Author_xml | – sequence: 1 givenname: Martin surname: Michl fullname: Michl, Martin organization: Medical University of Vienna – sequence: 2 givenname: Xuhui surname: Liu fullname: Liu, Xuhui organization: The First Affiliated Hospital of Zhengzhou University – sequence: 3 givenname: Alexandra surname: Kaider fullname: Kaider, Alexandra organization: Medical University of Vienna – sequence: 4 givenname: Amir surname: Sadeghipour fullname: Sadeghipour, Amir organization: Medical University of Vienna – sequence: 5 givenname: Bianca S. orcidid: 0000-0001-8940-8130 surname: Gerendas fullname: Gerendas, Bianca S. email: bianca.gerendas@meduniwien.ac.at organization: Medical University of Vienna – sequence: 6 givenname: Ursula orcidid: 0000-0002-7788-7311 surname: Schmidt‐Erfurth fullname: Schmidt‐Erfurth, Ursula organization: Medical University of Vienna |
| BookMark | eNp1kUtr3DAQx0VJaZJtD_0GglzSwybW0_YlEEKTFgI5NIXehCyP11psydFjy377KtkQaKG6jGbmNy_-p-jIeQcIfSbVBSnvUvt4Qbik5B06IbUQa1bL5ujtL34do9MYt1UliZT8AzpmtG1lTcgJ2j6OgO28aJOwH3BMIZuUg56wX5I1xRo_QgBnACc_-03Qy7jHZtRuAxF7h3c25oIN2Zlki28dDpCsK7EdFMcbM-VYMh_R-0FPET692hX6efv18ebb-v7h7vvN9f3acFqRtWCGct522nBBetLLnneMdIyDFjUlrIK6Hzjv-q7hRFStFrQbSDNoPvR1V3O2QleHvkvuZugNuFTuUUuwsw575bVVf2ecHdXG71TDRMvKhBU6f20Q_FOGmNRso4Fp0g58jqqsVwsuGW0KevYPuvU5lNsLJbigVLYVK9SXA2WCjzHA8LYMqdSzgqooqF4ULOzlgf1tJ9j_H1TXDz8OFX8AtF6flw |
| CitedBy_id | crossref_primary_10_1038_s41433_023_02647_0 crossref_primary_10_1007_s00347_022_01732_1 crossref_primary_10_1016_j_oret_2023_08_005 crossref_primary_10_1371_journal_pone_0257698 crossref_primary_10_3928_23258160_20230317_01 crossref_primary_10_12677_HJO_2023_123016 crossref_primary_10_3928_23258160_20220215_03 crossref_primary_10_1155_2021_6096017 crossref_primary_10_1038_s41433_022_02376_w crossref_primary_10_2147_OPTH_S457503 crossref_primary_10_1155_2022_3616044 |
| Cites_doi | 10.1016/j.ajo.2014.04.024 10.1016/j.ajo.2009.09.007 10.1097/IAE.0000000000000054 10.1136/bjophthalmol-2014-305186 10.1001/jamaophthalmol.2014.2350 10.1016/j.ophtha.2009.04.038 10.1016/j.ophtha.2011.02.038 10.1038/s41598-018-28013-9 10.1016/j.ophtha.2017.06.027 10.1016/j.ophtha.2011.02.022 10.4103/jovr.jovr_264_17 10.1111/j.1442-9071.2009.01914.x 10.1001/jamaophthalmol.2018.4516 10.1007/s00417-014-2595-5 10.1007/s00417-009-1167-6 10.1016/j.ophtha.2011.12.028 10.1016/j.ophtha.2015.09.013 10.1016/j.ophtha.2008.10.017 10.1038/s41551-018-0195-0 10.1155/2013/974670 10.1016/j.ophtha.2010.06.034 10.2147/OPTH.S110793 10.1016/j.ophtha.2014.01.027 10.1016/j.ophtha.2014.11.017 10.1001/archopht.117.6.821 10.1109/TMI.2017.2700213 10.1007/s00417-009-1151-1 10.1016/j.ophtha.2017.10.031 10.1016/j.ophtha.2016.02.030 10.5301/ejo.5000162 10.1136/bjo.2007.118497 10.1167/iovs.10-6097 10.1167/iovs.16-20201 10.1097/IAE.0000000000001070 10.1016/j.ajo.2014.07.027 10.1016/j.ophtha.2016.01.011 10.1016/j.ophtha.2007.04.052 10.1007/s00417-010-1419-5 10.1007/s00417-012-2067-8 10.1111/j.1755-3768.2010.02063.x 10.1097/IAE.0000000000001579 10.1016/j.ophtha.2013.01.073 10.1056/NEJMcp1003934 10.1167/iovs.08-2510 10.1016/j.ophtha.2012.01.042 |
| ContentType | Journal Article |
| Copyright | 2020 The Authors. published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation 2020. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2020 The Authors. published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation – notice: 2020. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P WIN AAYXX CITATION 7TK 7X8 5PM |
| DOI | 10.1111/aos.14621 |
| DatabaseName | Open Access: Wiley-Blackwell Open Access Journals Wiley Journals CrossRef Neurosciences Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef Neurosciences Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Neurosciences Abstracts CrossRef |
| Database_xml | – sequence: 1 dbid: 24P name: Open Access: Wiley-Blackwell Open Access Journals url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | acta ophthalmologica 2020 |
| EISSN | 1755-3768 |
| EndPage | 426 |
| ExternalDocumentID | 10_1111_aos_14621 AOS14621 |
| Genre | article |
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OC 23M 24P 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACGFS ACGOF ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FIJ FUBAC G-S GODZA H.X HF~ HGLYW HZI HZ~ IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2W P2X P2Z P4B P4D P6G PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SUPJJ SV3 TEORI TR2 TUS UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 ~IA ~WT AAYXX CITATION 7TK 7X8 5PM |
| ID | FETCH-LOGICAL-c4201-53c2449bac451d1d6d4b31b34ea572130e7df44bdb841509a52bf18fa4fd7b743 |
| IEDL.DBID | DR2 |
| ISSN | 1755-375X |
| IngestDate | Tue Sep 17 20:59:47 EDT 2024 Fri Aug 16 04:23:39 EDT 2024 Thu Oct 10 16:44:50 EDT 2024 Fri Aug 23 02:15:48 EDT 2024 Sat Aug 24 01:05:22 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | Attribution This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4201-53c2449bac451d1d6d4b31b34ea572130e7df44bdb841509a52bf18fa4fd7b743 |
| Notes | analysis. Furthermore, they thank the staff of the VRC who contributed to the image readings. MM, XL, AK: no financial disclosures. BG: Novartis/Kinarus/IDx – all unrelated to this study. USE: Bayer/Novartis/Böhringer‐Ingelheim/Alcon/Kinarus – all unrelated to this study. post hoc The authors would like to express their gratitude to all investigators of the clinical trials used for this The Medical University of Vienna received money for its central reading services of the CRYSTAL and BRIGHTER studies at the Vienna Reading Center. Novartis, Basel, Switzerland had no role in the planning of the submitted study. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 The authors would like to express their gratitude to all investigators of the clinical trials used for this post hoc analysis. Furthermore, they thank the staff of the VRC who contributed to the image readings. |
| ORCID | 0000-0001-8940-8130 0000-0002-7788-7311 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Faos.14621 |
| PMID | 32996711 |
| PQID | 2545226903 |
| PQPubID | 1036384 |
| PageCount | 9 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8359321 proquest_miscellaneous_2447546328 proquest_journals_2545226903 crossref_primary_10_1111_aos_14621 wiley_primary_10_1111_aos_14621_AOS14621 |
| PublicationCentury | 2000 |
| PublicationDate | June 2021 |
| PublicationDateYYYYMMDD | 2021-06-01 |
| PublicationDate_xml | – month: 06 year: 2021 text: June 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | Malden |
| PublicationPlace_xml | – name: Malden – name: Hoboken |
| PublicationTitle | Acta ophthalmologica (Oxford, England) |
| PublicationYear | 2021 |
| Publisher | Wiley Subscription Services, Inc John Wiley and Sons Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc – name: John Wiley and Sons Inc |
| References | 2015; 56 2011; 118 2010; 248 2010; 149 2015; 122 2018; 125 2016; 10 2010; 363 2016; 123 2011; 52 2007; 91 2013; 120 2014; 132 2014; 252 2016; 36 2014; 158 2016; 57 2012; 53 2009; 116 2018; 8 2018; 2 2017; 58 2013; 2013 2017; 36 2009; 50 2017; 10 2019; 137 2018 2013; 251 2011; 89 2008; 115 1999; 117 2014; 121 2018; 11 2017; 124 2012; 22 2018; 38 2014; 34 2012; 119 2009; 247 2018; 15 2009; 37 2016; 9 2014; 98 2018; 13 e_1_2_5_25_1 e_1_2_5_48_1 e_1_2_5_46_1 e_1_2_5_21_1 Kim HJ (e_1_2_5_23_1) 2018; 11 e_1_2_5_44_1 Philip A‐M (e_1_2_5_32_1) 2016; 57 e_1_2_5_42_1 e_1_2_5_40_1 e_1_2_5_38_1 e_1_2_5_17_1 e_1_2_5_36_1 e_1_2_5_9_1 e_1_2_5_11_1 e_1_2_5_34_1 e_1_2_5_57_1 e_1_2_5_7_1 e_1_2_5_13_1 e_1_2_5_55_1 e_1_2_5_5_1 e_1_2_5_3_1 e_1_2_5_19_1 Liu M (e_1_2_5_28_1) 2015; 56 e_1_2_5_30_1 e_1_2_5_51_1 e_1_2_5_49_1 e_1_2_5_26_1 e_1_2_5_47_1 e_1_2_5_24_1 e_1_2_5_22_1 e_1_2_5_43_1 Pikkel J (e_1_2_5_33_1) 2013; 2013 e_1_2_5_20_1 e_1_2_5_41_1 Wang MZ (e_1_2_5_53_1) 2016; 9 Gerendas BS (e_1_2_5_15_1) 2017; 58 e_1_2_5_14_1 Liu H (e_1_2_5_27_1) 2018; 15 e_1_2_5_39_1 e_1_2_5_16_1 e_1_2_5_37_1 Simader C (e_1_2_5_45_1) 2012; 53 e_1_2_5_8_1 e_1_2_5_10_1 e_1_2_5_56_1 e_1_2_5_6_1 e_1_2_5_12_1 e_1_2_5_54_1 Abdulaal M (e_1_2_5_2_1) 2015; 56 e_1_2_5_4_1 e_1_2_5_18_1 e_1_2_5_31_1 e_1_2_5_52_1 e_1_2_5_50_1 Mo B (e_1_2_5_29_1) 2017; 10 Qin YW (e_1_2_5_35_1) 2017; 10 |
| References_xml | – volume: 363 start-page: 2135 year: 2010 end-page: 2144 article-title: Clinical practice. Retinal‐vein occlusion publication-title: N Engl J Med – volume: 38 start-page: 559 year: 2018 end-page: 568 article-title: Ranibizumab for retinal vein occlusion: predictive factors and long‐term outcomes in real‐life data publication-title: Retina – volume: 116 start-page: 504 year: 2009 end-page: 512 article-title: SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion publication-title: Ophthalmology – volume: 2013 start-page: 974670 year: 2013 article-title: Bevacizumab for CRVO associated CME: effect of timing and frequency of injections on final visual outcome publication-title: J Ophthalmol – volume: 119 start-page: 1024 year: 2012 end-page: 1032 article-title: Vascular endothelial growth factor Trap‐Eye for macular edema secondary to central retinal vein occlusion: six‐month results of the phase 3 COPERNICUS study publication-title: Ophthalmology – volume: 98 start-page: 1629 year: 2014 end-page: 1635 article-title: Intraretinal cysts are the most relevant prognostic biomarker in neovascular age‐related macular degeneration independent of the therapeutic strategy publication-title: Br J Ophthalmol – volume: 248 start-page: 1567 year: 2010 end-page: 1572 article-title: OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion publication-title: Graefes Arch Clin Exp Ophthalmol – volume: 52 start-page: 3334 year: 2011 end-page: 3337 article-title: Predictors of short‐term visual outcome after anti‐VEGF therapy of macular edema due to central retinal vein occlusion publication-title: Invest Ophthalmol Vis Sci – volume: 247 start-page: 1635 year: 2009 end-page: 1641 article-title: Long‐term follow‐up of OCT‐guided bevacizumab treatment of macular edema due to retinal vein occlusion publication-title: Graefes Arch Clin Exp Ophthalmol – volume: 137 start-page: 46 year: 2019 end-page: 47 article-title: Disorganization of retinal inner layers and the importance of setting boundaries publication-title: JAMA Ophthalmol – volume: 22 start-page: 1013 year: 2012 end-page: 1018 article-title: Visual acuity outcome and predictive factors after bevacizumab for central retinal vein occlusion publication-title: Eur J Ophthalmol – year: 2018 – volume: 115 start-page: 355 year: 2008 end-page: 362 article-title: Three‐dimensional imaging of cystoid macular edema in retinal vein occlusion publication-title: Ophthalmology – volume: 56 start-page: 5802 year: 2015 article-title: Baseline predictors of early visual acuity improvement in RVO patients treated with ranibizumab in the SHORE study ARVO publication-title: Investig Ophthalmol Vis Sci – volume: 158 start-page: 1032 year: 2014 end-page: 1038 article-title: Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18‐month results of the phase 3 GALILEO study publication-title: Am J Ophthalmol – volume: 91 start-page: 1644 year: 2007 end-page: 1649 article-title: Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion publication-title: Br J Ophthalmol – volume: 53 start-page: 4067 year: 2012 article-title: Retinal thickness measurements with spectral domain optical coherence devices from different manufacturers in a reading center environment publication-title: Invest Ophthalmol Vis Sci – volume: 10 start-page: 605 year: 2017 end-page: 612 article-title: Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion publication-title: Int J ophthal – volume: 149 start-page: 291 year: 2010 end-page: 301 article-title: Serous retinal detachment associated with retinal vein occlusion publication-title: Am J Ophthalmol – volume: 117 start-page: 821 year: 1999 end-page: 823 article-title: Muller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacualr retinoschisis publication-title: Arch Ophthalmol – volume: 251 start-page: 501 year: 2013 end-page: 508 article-title: Spectral‐domain optical coherence tomography (SD‐OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion publication-title: Graefes Arch Clin Exp Ophthalmol – volume: 118 start-page: 2041 year: 2011 end-page: 2049 article-title: Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve‐month outcomes of a phase III study publication-title: Ophthalmology – volume: 118 start-page: 345 year: 2011 end-page: 352 article-title: Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10 publication-title: Ophthalmology – volume: 248 start-page: 155 year: 2010 end-page: 159 article-title: Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion publication-title: Graefes Arch Clin Exp Ophthalmol – volume: 124 start-page: 1778 year: 2017 end-page: 1787 article-title: Sustained benefits of ranibizumab with or without laser in branch retinal vein occlusion: 24‐month results of the BRIGHTER Study publication-title: Ophthalmology – volume: 13 start-page: 315 year: 2018 end-page: 332 article-title: Optical coherence tomography angiography in eyes with retinal vein occlusion publication-title: J Ophthalmic Vis Res – volume: 89 start-page: 35 year: 2011 end-page: 40 article-title: Association between integrity of foveal photoreceptor layer and visual outcome in retinal vein occlusion publication-title: Acta Ophthalmol – volume: 36 start-page: 2319 year: 2016 end-page: 2328 article-title: Hyperreflective foci as an independent visual outcome predictor in macular edema due to retinal vascular diseases treated with intravitreal dexamethasone or ranibizumab publication-title: Retina – volume: 132 start-page: 1309 year: 2014 end-page: 1316 article-title: Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center‐involved diabetic macular edema publication-title: JAMA Ophthalmol – volume: 56 start-page: 5959 year: 2015 article-title: Reproducibility of disorganization of the retinal inner layers (DRIL) grading across spectral domain optical coherence tomography (SDOCT) model and scan types in eyes with diabetic macular edema (DME) publication-title: Invest Ophthalmol Vis Sci – volume: 121 start-page: 1414 year: 2014 end-page: 1420 article-title: Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two‐year results from the COPERNICUS study publication-title: Ophthalmology – volume: 123 start-page: 1332 year: 2016 end-page: 1344 article-title: Individualized stabilization criteria‐driven ranibizumab versus laser in branch retinal vein occlusion: six‐month results of BRIGHTER publication-title: Ophthalmology – volume: 8 start-page: 9626 year: 2018 article-title: Relationship between Optical Intensity on Optical Coherence Tomography and Retinal Ischemia in Branch Retinal Vein Occlusion publication-title: Sci Rep – volume: 11 start-page: 256 year: 2018 end-page: 261 article-title: Correlation between macular ganglion cell‐inner plexiform layer thickness and visual acuity after resolution of the macular edema secondary to central retinal vein occlusion publication-title: Int J Ophthal – volume: 50 start-page: 1025 year: 2009 end-page: 1032 article-title: Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab publication-title: Invest Ophthalmol Vis Sci – volume: 158 start-page: 372 year: 2014 end-page: 380 article-title: Paracentral acute middle maculopathy in nonischemic central retinal vein occlusion publication-title: Am J Ophthalmol – volume: 10 start-page: 271 year: 2017 end-page: 276 article-title: Characteristics of retinal vein occlusion with final vision better than 78 letters after sequential therapy with ranibizumab and triamcinolone acetate publication-title: Int J Ophthalmol – volume: 118 start-page: 1594 year: 2011 end-page: 1602 article-title: Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12‐month outcomes of a phase III study publication-title: Ophthalmology – volume: 116 start-page: 2158 year: 2009 end-page: 2164 article-title: Monitoring ocular drug therapy by analysis of aqueous samples publication-title: Ophthalmology – volume: 58 start-page: 4039 year: 2017 end-page: 4048 article-title: Spatial correspondence between intraretinal fluid, subretinal fluid, and pigment epithelial detachment in neovascular age‐related macular degeneration publication-title: Invest Ophthalmol Vis Sci – volume: 36 start-page: 1773 year: 2017 end-page: 1783 article-title: Predicting macular edema recurrence from spatio‐temporal signatures in optical coherence tomography images publication-title: IEEE Trans Med Imaging – volume: 123 start-page: 1101 year: 2016 end-page: 1111 article-title: Individualized ranibizumab regimen driven by stabilization criteria for central retinal vein occlusion: twelve‐month results of the CRYSTAL Study publication-title: Ophthalmology – volume: 37 start-page: 208 year: 2009 end-page: 216 article-title: Evaluation of potential visual acuity in eyes with macular oedema secondary to retinal vein occlusion publication-title: Clin Exp Ophthal – volume: 125 start-page: 549 year: 2018 end-page: 558 article-title: Fully automated detection and quantification of macular fluid in OCT using deep learning publication-title: Ophthalmology – volume: 119 start-page: 1190 year: 2012 end-page: 1198 article-title: Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant publication-title: Ophthalmology – volume: 15 start-page: 890 year: 2018 end-page: 896 article-title: Predicting the visual acuity for retinal vein occlusion after ranibizumab therapy with an original ranking for macular microstructure publication-title: Exp Therapeut Med – volume: 122 start-page: 822 year: 2015 end-page: 832 article-title: Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age‐related macular degeneration publication-title: Ophthalmology – volume: 57 start-page: 4164 year: 2016 article-title: Presence of subretinal fluid at baseline preserves from photoreceptor alterations in diabetic macular edema and cystoid macular edema due to central retinal vein occlusion publication-title: Invest Ophthalmol Vis Sci – volume: 2 start-page: 158 year: 2018 end-page: 164 article-title: Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning publication-title: Nat Biomed Eng – volume: 120 start-page: 1860 year: 2013 end-page: 1870 article-title: Macular morphology and visual acuity in the comparison of age‐related macular degeneration treatments trials publication-title: Ophthalmology – volume: 252 start-page: 1413 year: 2014 end-page: 1421 article-title: Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after intravitreal bevacizumab for macular edema in branch retinal vein occlusion publication-title: Graefes Arch Clin Exp Ophthalmol – volume: 9 start-page: 86 year: 2016 end-page: 92 article-title: Predictors of short‐term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion publication-title: Int J Ophthalmol – volume: 58 start-page: 2026 year: 2017 article-title: OCT biomarkers predictive for visual acuity in patients with diabetic macular edema publication-title: Invest Ophthalmol Vis Sci – volume: 123 start-page: 60 year: 2016 end-page: 69 article-title: Predictive value of retinal morphology for visual acuity outcomes of different ranibizumab treatment regimens for neovascular AMD publication-title: Ophthalmology – volume: 34 start-page: 1132 year: 2014 end-page: 1141 article-title: Optical coherence tomography predicts visual outcome in acute central retinal vein occlusion publication-title: Retina – volume: 10 start-page: 1305 year: 2016 end-page: 1313 article-title: Optical coherence tomography parameters predictive of visual outcome after anti‐VEGF therapy for retinal vein occlusion publication-title: Clin Ophthalmol – ident: e_1_2_5_36_1 doi: 10.1016/j.ajo.2014.04.024 – ident: e_1_2_5_50_1 doi: 10.1016/j.ajo.2009.09.007 – ident: e_1_2_5_25_1 doi: 10.1097/IAE.0000000000000054 – ident: e_1_2_5_37_1 doi: 10.1136/bjophthalmol-2014-305186 – ident: e_1_2_5_46_1 doi: 10.1001/jamaophthalmol.2014.2350 – ident: e_1_2_5_7_1 doi: 10.1016/j.ophtha.2009.04.038 – ident: e_1_2_5_6_1 doi: 10.1016/j.ophtha.2011.02.038 – volume: 56 start-page: 5802 year: 2015 ident: e_1_2_5_28_1 article-title: Baseline predictors of early visual acuity improvement in RVO patients treated with ranibizumab in the SHORE study ARVO publication-title: Investig Ophthalmol Vis Sci contributor: fullname: Liu M – ident: e_1_2_5_10_1 doi: 10.1038/s41598-018-28013-9 – volume: 15 start-page: 890 year: 2018 ident: e_1_2_5_27_1 article-title: Predicting the visual acuity for retinal vein occlusion after ranibizumab therapy with an original ranking for macular microstructure publication-title: Exp Therapeut Med contributor: fullname: Liu H – ident: e_1_2_5_48_1 doi: 10.1016/j.ophtha.2017.06.027 – ident: e_1_2_5_5_1 doi: 10.1016/j.ophtha.2011.02.022 – ident: e_1_2_5_49_1 doi: 10.4103/jovr.jovr_264_17 – volume: 57 start-page: 4164 year: 2016 ident: e_1_2_5_32_1 article-title: Presence of subretinal fluid at baseline preserves from photoreceptor alterations in diabetic macular edema and cystoid macular edema due to central retinal vein occlusion publication-title: Invest Ophthalmol Vis Sci contributor: fullname: Philip A‐M – ident: e_1_2_5_38_1 doi: 10.1111/j.1442-9071.2009.01914.x – ident: e_1_2_5_40_1 doi: 10.1001/jamaophthalmol.2018.4516 – ident: e_1_2_5_22_1 doi: 10.1007/s00417-014-2595-5 – ident: e_1_2_5_3_1 doi: 10.1007/s00417-009-1167-6 – volume: 56 start-page: 5959 year: 2015 ident: e_1_2_5_2_1 article-title: Reproducibility of disorganization of the retinal inner layers (DRIL) grading across spectral domain optical coherence tomography (SDOCT) model and scan types in eyes with diabetic macular edema (DME) publication-title: Invest Ophthalmol Vis Sci contributor: fullname: Abdulaal M – ident: e_1_2_5_16_1 – ident: e_1_2_5_57_1 doi: 10.1016/j.ophtha.2011.12.028 – volume: 10 start-page: 605 year: 2017 ident: e_1_2_5_29_1 article-title: Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion publication-title: Int J ophthal contributor: fullname: Mo B – ident: e_1_2_5_52_1 doi: 10.1016/j.ophtha.2015.09.013 – ident: e_1_2_5_43_1 doi: 10.1016/j.ophtha.2008.10.017 – ident: e_1_2_5_34_1 doi: 10.1038/s41551-018-0195-0 – volume: 2013 start-page: 974670 year: 2013 ident: e_1_2_5_33_1 article-title: Bevacizumab for CRVO associated CME: effect of timing and frequency of injections on final visual outcome publication-title: J Ophthalmol doi: 10.1155/2013/974670 contributor: fullname: Pikkel J – ident: e_1_2_5_42_1 doi: 10.1016/j.ophtha.2010.06.034 – ident: e_1_2_5_12_1 doi: 10.2147/OPTH.S110793 – ident: e_1_2_5_17_1 doi: 10.1016/j.ophtha.2014.01.027 – ident: e_1_2_5_41_1 doi: 10.1016/j.ophtha.2014.11.017 – ident: e_1_2_5_14_1 doi: 10.1001/archopht.117.6.821 – volume: 10 start-page: 271 year: 2017 ident: e_1_2_5_35_1 article-title: Characteristics of retinal vein occlusion with final vision better than 78 letters after sequential therapy with ranibizumab and triamcinolone acetate publication-title: Int J Ophthalmol contributor: fullname: Qin YW – ident: e_1_2_5_51_1 doi: 10.1109/TMI.2017.2700213 – ident: e_1_2_5_18_1 doi: 10.1007/s00417-009-1151-1 – ident: e_1_2_5_39_1 doi: 10.1016/j.ophtha.2017.10.031 – ident: e_1_2_5_47_1 doi: 10.1016/j.ophtha.2016.02.030 – volume: 53 start-page: 4067 year: 2012 ident: e_1_2_5_45_1 article-title: Retinal thickness measurements with spectral domain optical coherence devices from different manufacturers in a reading center environment publication-title: Invest Ophthalmol Vis Sci contributor: fullname: Simader C – ident: e_1_2_5_11_1 doi: 10.5301/ejo.5000162 – ident: e_1_2_5_31_1 doi: 10.1136/bjo.2007.118497 – ident: e_1_2_5_54_1 doi: 10.1167/iovs.10-6097 – ident: e_1_2_5_24_1 doi: 10.1167/iovs.16-20201 – ident: e_1_2_5_8_1 doi: 10.1097/IAE.0000000000001070 – volume: 9 start-page: 86 year: 2016 ident: e_1_2_5_53_1 article-title: Predictors of short‐term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion publication-title: Int J Ophthalmol contributor: fullname: Wang MZ – ident: e_1_2_5_30_1 doi: 10.1016/j.ajo.2014.07.027 – ident: e_1_2_5_26_1 doi: 10.1016/j.ophtha.2016.01.011 – ident: e_1_2_5_56_1 doi: 10.1016/j.ophtha.2007.04.052 – ident: e_1_2_5_19_1 doi: 10.1007/s00417-010-1419-5 – ident: e_1_2_5_21_1 doi: 10.1007/s00417-012-2067-8 – volume: 11 start-page: 256 year: 2018 ident: e_1_2_5_23_1 article-title: Correlation between macular ganglion cell‐inner plexiform layer thickness and visual acuity after resolution of the macular edema secondary to central retinal vein occlusion publication-title: Int J Ophthal contributor: fullname: Kim HJ – ident: e_1_2_5_44_1 doi: 10.1111/j.1755-3768.2010.02063.x – ident: e_1_2_5_9_1 doi: 10.1097/IAE.0000000000001579 – ident: e_1_2_5_20_1 doi: 10.1016/j.ophtha.2013.01.073 – volume: 58 start-page: 2026 year: 2017 ident: e_1_2_5_15_1 article-title: OCT biomarkers predictive for visual acuity in patients with diabetic macular edema publication-title: Invest Ophthalmol Vis Sci contributor: fullname: Gerendas BS – ident: e_1_2_5_55_1 doi: 10.1056/NEJMcp1003934 – ident: e_1_2_5_13_1 doi: 10.1167/iovs.08-2510 – ident: e_1_2_5_4_1 doi: 10.1016/j.ophtha.2012.01.042 |
| SSID | ssj0061664 |
| Score | 2.4129696 |
| Snippet | Purpose
We aimed to determine the correlation between optical coherence tomography (OCT)‐ and demographic features and baseline best corrected visual acuity... Abstract Purpose We aimed to determine the correlation between optical coherence tomography (OCT)‐ and demographic features and baseline best corrected visual... PurposeWe aimed to determine the correlation between optical coherence tomography (OCT)‐ and demographic features and baseline best corrected visual acuity... PURPOSEWe aimed to determine the correlation between optical coherence tomography (OCT)- and demographic features and baseline best corrected visual acuity... |
| SourceID | pubmedcentral proquest crossref wiley |
| SourceType | Open Access Repository Aggregation Database Publisher |
| StartPage | 418 |
| SubjectTerms | Acuity biomarker Cysts Diabetes mellitus Diabetic retinopathy function morphology Occlusion optical coherence tomography Original Retina retinal vein occlusion Retinopathy Statistical analysis Tomography Visual perception |
| Title | The impact of structural optical coherence tomography changes on visual function in retinal vein occlusion |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Faos.14621 https://www.proquest.com/docview/2545226903 https://search.proquest.com/docview/2447546328 https://pubmed.ncbi.nlm.nih.gov/PMC8359321 |
| Volume | 99 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RDlUvBfpQFxbkVj30ErRObGdXnBAFISTaqi3SHipFfkUsLTFSdvfAr2fGeZRFQkLcEtnRJJ6Z-PN45jPAZ5PnXHN0JJ8blQgx8omWk5IKdS2uH6RzkqqRz7-p0wtxNpXTNTjoamEafog-4EaeEf_X5ODa1PecXIea3DwWkfMsp3Surz976ijFVaSOwtlRohPJacsqRFk8_ZOrc9F_gPkwPfI-bI3zzskG_OneuEk3-bu_mJt9e_uAzPGZn7QJr1s8yg4bA9qCNV-9gZfn7Y77W7hCO2JNKSULJWvoZomqg4WbGAZnNlw2JYNsHq5bAmzW1BPXLFRsOasX2I0mUDICNqsYVU6S1KXHm2DtvwXF7N7Bxcnx76PTpD2fIbECcUMiM4vgYGK0FZI77pQTJuMmE15LXFhmI5-7UgjjzBhhwmiiZWpKPi61KF1uELq8h_UqVP4DsJQbq5VWNh1z4STaTYlQb6wtolllhB7Ap05TxU1Dw1F0yxcctSKO2gCGnQ6L1hPrIqVD1FM1GWUD-Ng3ow_RxoiufFhgH2I9FAoFDiBf0X0vjFi4V1uq2WVk40YIixgYhX-Jqn389YrD77_ixfbTu-7Aq5SSaGLYZwjrqGS_iyhobvbgRSp-7EWjvwMLVwdZ |
| link.rule.ids | 230,315,783,787,888,1378,11574,27936,27937,46064,46306,46488,46730 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hkNpeSp9igbYu6qGXoHViO7sSF9QWbVuWSi1Ie6kivyIWSoy0uxz49cw4D1gkJNRbIjty4pkv_jz2fAb4ZPKca45A8rlRiRB9n2g5LClR1-L8QTonKRt5fKRGJ-LHRE5WYK_Nhan1IbqAGyEj_q8J4BSQvoNyHWaEc8oiX0O4Z3Rww9ffnXiU4iqKR-H4KBFGctLoCtE-nu7R5dHolmLe3yB5l7jGkedgHf6271xvODnfXczNrr2-J-f4vx_1Ap43lJTt1z70ElZ89QqejJtF99dwhq7E6mxKFkpWK86SWgcLlzESzmw4rbMG2TxcNBrYrE4pnrFQsavpbIHVaAwlP2DTilHyJLV65fEmWPtvQWG7N3By8O34yyhpjmhIrEDqkMjMIj8YGm2F5I475YTJuMmE1xLnllnf564UwjgzQKbQH2qZmpIPSi1KlxtkL29htQqV3wCWcmO10sqmAy6cRNcpke0NtEVCq4zQPdhpTVVc1kocRTuDwV4rYq_1YLs1YtGAcVakdI56qob9rAcfu2KEEa2N6MqHBdYh4UOhsMEe5EvG7xojIe7lkmp6GgW5kcUiDcbGP0fbPvx6xf6vP_Fi8_FVP8DT0fH4sDj8fvRzC56ltKcmRoG2YRUN7t8hKZqb99H3bwAlxQqa |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CAqGXtmlTum3aqKWHXBxWtiR7ySm0WdJH0pA2sIeC0ctk-7AWdjeH_PrMyI9kA4XSm41kZGtmPJ9GM58A3pk855qjIfncqESIoU-0HFVUqGtx_SCdk1SNfHKqji_Ep4mcrMFBVwvT8EP0ATeyjPi_JgOfueqOkeswJzOnIvINoRD5EiI677mjFFeROwrdo0QrkpOWVojSePpHV53RLcK8nx95F7dGxzN-BD-6V27yTX7tLxdm317fY3P8z296DA9bQMoOGw3agjVfP4HNk3bL_Sn8REViTS0lCxVr-GaJq4OFWYyDMxsum5pBtgh_WgZs1hQUz1mo2dV0vsRu5EFJC9i0ZlQ6SaNeebwJ1v5eUtBuGy7GR9_fHyftAQ2JFQgcEplZRAcjo62Q3HGnnDAZN5nwWuLKMhv63FVCGGcKxAnDkZapqXhRaVG53CB2eQbrdaj9c2ApN1YrrWxacOEkKk6FWK_QFuGsMkIP4G0nqXLW8HCU3foFZ62MszaAnU6GZWuK8zKlU9RTNRpmA3jTN6MR0c6Irn1YYh-iPUQlSosB5Cuy7wcjGu7Vlnp6Gem4EcMiCMbB96Jo__565eHXb_Hixb933YXNsw_j8svH088v4UFKCTUxBLQD6yhv_woR0cK8jpp_Aw2cCUk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+impact+of+structural+optical+coherence+tomography+changes+on+visual+function+in+retinal+vein+occlusion&rft.jtitle=Acta+ophthalmologica+%28Oxford%2C+England%29&rft.au=Michl%2C+Martin&rft.au=Liu%2C+Xuhui&rft.au=Kaider%2C+Alexandra&rft.au=Sadeghipour%2C+Amir&rft.date=2021-06-01&rft.issn=1755-375X&rft.eissn=1755-3768&rft.volume=99&rft.issue=4&rft.spage=418&rft.epage=426&rft_id=info:doi/10.1111%2Faos.14621&rft.externalDBID=10.1111%252Faos.14621&rft.externalDocID=AOS14621 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1755-375X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1755-375X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1755-375X&client=summon |